Skip to main content
HR 2069 116th Congress House Health Business records Civil actions and liability Corporate finance and management Government information and archives Health care costs and insurance Inflation and prices Manufacturing Prescription drugs

SPIKE Act

Introduced: April 3, 2019 Introduced by: Horsford, Steven Democratic · Nevada See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 21, 2019
Subcommittee Hearings Held.
Apr 4, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Subcommittee on Health.
Apr 3, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 3, 2019
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act

This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.

What's happening now May 21, 2019

Subcommittee Hearings Held.

 Related & companion bills 1
  • HR 2113 Related bill Prescription Drug STAR Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 7
All 7 Democratic 5 Republican 1
R
Steil, Bryan
Wisconsin · Nov 18, 2019
 D
Norton, Eleanor Holmes
District of Columbia · May 20, 2019
 D
Slotkin, Elissa
Michigan · May 20, 2019
 D
Case, Ed
Hawaii · Apr 30, 2019
 D
Houlahan, Chrissy
Pennsylvania · Apr 30, 2019
 D
Raskin, Jamie
Maryland · Apr 30, 2019
Reed, Tom
· Apr 3, 2019
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2069: SPIKE Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-2069/
MLA
"H.R. 2069: SPIKE Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-2069/.
Bluebook (legal)
H.R. 2069, 116th Cong. (2026), https://openamerica.io/bill/116-HR-2069/.
Markdown link
[H.R. 2069: SPIKE Act](https://openamerica.io/bill/116-HR-2069/)
Report a problem